Table 2.
Characteristics of the test treatment (final analysis set).
Characteristic | |
---|---|
Presence of aura in the test treatment, % (n/N) | 31.9 (29/91) |
Baseline pain severity in the test treatment, % (n/N) | |
Mild | 20.9 (19/91) |
Moderate | 59.3 (54/91) |
Severe | 19.8 (18/91) |
Presence of baseline associated symptoms in the test treatment, % (n/N) | |
Nausea or vomiting | 45.1 (41/91) |
Photophobia | 81.3 (74/91) |
Phonophobia | 71.4 (65/91) |
Baseline functional disability, % (n/N) | |
No limitation | 43.8 (32/73) |
Some limitation | 41.1 (30/73) |
Moderate limitation | 15.1 (11/73) |
Severe limitation | 0 (0/73) |
Time from headache onset, % (n/N), min | |
0–30 | 73 (66/91) |
30–60 | 22 (20/91) |
60 or more | 5 (5/91) |
The number of observations analyzed vary by parameter because of missing values.